Dale Beermann: We’re seeing a Consumerization in Healthcare (JPM Week Exclusive Video)

• 10,000 attendees and over 450 private & public companies attend JPM week.
• Digital health startup Redox threw a packed social mixer in SoMa on Tuesday.
• Pacific Labs CEO Dale Beermann is excited to witness the consumerization of healthcare.

The 36th Annual JP Morgan Healthcare Conference went down this week in our backyard of San Francisco.

Otherwise known as JPM Week, it’s an opportune time to get out and network amongst our peers in the Health Care industry.

Dale Beermann: Biggest Concern for Digital Health in 2018

On Tuesday we attended the Redox social mixer at Uno Dos Tacos in the SoMa district.

While there, I got a chance to catchup with Pacifica Labs CEO Dale Beermann.

Here’s the transcript from our conversation:

Dale Beermann: One of the things that we have to see are a lot of these digital therapeutics establishing very rigorous efficacy standards. I think what what is really exciting is that we’re starting to see this consumerization of healthcare happening.

But what I’m concerned about is that a lot of the tools that you see are developed for the consumer, but with the provider or the payer in mind. Ultimately if we aren’t addressing the pathways through which these consumers are addressing, in our case mental healthcare, but really it’s every aspect of healthcare.

If we aren’t taking a look at how that individual is receiving access to care and what that continuum really looks like, I feel like we are going to continue losing people every single step of the way.

We just have to find better ways to incorporate them into the healthcare setting and address their needs, not the needs of every single healthcare institution out there.

Hoala Greevy: Got it! Thanks Dale.

About Pacifica Labs

Pacifica Labs is a mobile application that empowers individuals to take control of their stress and anxiety by moving care into their daily lives.

Quick, engaging exercises teach users to manage and cope with their anxiety, in turn reducing the financial burden of payers, both individual and institutional.